Kevin Michael Coveney
CIK: 0001967056
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Enveric Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 1, 2026ENVB
Enveric Biosciences, Inc.
Award(A)Direct133.3K shares- - Dec 23, 2025ENVB
Enveric Biosciences, Inc.
Award(A)Direct40.2K shares- - May 8, 2025ENVB
Enveric Biosciences, Inc.
Award(A)Direct74.2K shares- - Oct 9, 2024ENVB
Enveric Biosciences, Inc.
Award(A)Direct100K shares-
1-4 of 4 transactions
About Coveney Kevin Michael
Coveney Kevin Michael (SEC CIK 0001967056) files insider reports with the SEC as Chief Financial Officer of Enveric Biosciences, Inc. (ENVB).
Signal8 holds 4 ownership filings by Coveney Kevin Michael, all Form 4s, filed between Oct 11, 2024 and Jun 3, 2026. Those filings report 4 transactions, from Oct 9, 2024 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Coveney Kevin Michael's filings is in CAMBRIDGE, MA.
Recent filings by Coveney Kevin Michael
Other insiders filing for Enveric Biosciences, Inc. (ENVB)
- Tucker Joseph Edward, Chief Executive Officer
- PASQUALONE FRANK, Director
- WEBB MICHAEL D, Director
- Schabacker Marcus, Director
- Kegler George A., Director
- DeWitt Sheila, Director